BusinessWorld Renowned Veterinary Nutritionist Dr. R. Geoffrey Broderick Continues Groundbreaking Efforts to Help Animals by Joining PetLife Pharmaceuticals, Inc. as the Chairman of Product Development and Advisory BoardBy Nasdaq OMXFeb 9, 2017, 1:02 PM UTC
BusinessWorld Renowned Veterinary Nutritionist Dr. R. Geoffrey Broderick Continues Groundbreaking Efforts to Help Animals by Joining PetLife Pharmaceuticals, Inc. as the Chairman of Product Development and Advisory BoardBy Nasdaq OMXFeb 9, 2017, 1:02 PM UTC
BusinessWorld Renowned Veterinary Nutritionist Dr. R. Geoffrey Broderick Continues Groundbreaking Efforts to Help Animals by Joining PetLife Pharmaceuticals, Inc. as the Chairman of Product Development and Advisory BoardBy Nasdaq OMXFeb 9, 2017, 1:02 PM UTC
BusinessPetLife Pharmaceuticals reports the First of Three Preclinical Studies in their pre-INAD Process for Vitalzul. Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions across Multiple Dosing Levels.By Nasdaq OMXJan 10, 2017, 1:00 PM UTC
BusinessCorrection: PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product LineBy Nasdaq OMXDec 7, 2016, 1:50 PM UTC
BusinessPetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™By Nasdaq OMXNov 15, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™By Nasdaq OMXNov 15, 2016, 1:01 PM UTC
BusinessPetLife Pharmaceuticals Announces the Addition of a Seasoned Marketing Specialist and Investor, Mrs. Vyvyan Campbell, to the Board of DirectorsBy Nasdaq OMXOct 24, 2016, 4:00 PM UTC
